September 25th, 2017
 
Home
About Us
Buildings
Our Sponsors
News
Links
Contact
 

Sirti Bestows Award of Honor
October 21, 2010. Billie Moreland, PhD, of Billie Moreland and Associates and Steve Simmons, PhD, E...

Triangle %u201CGraduates%u201D at Sweet Sixteen
The Idea (1994)
In June 1994, while on a layover in the San Francisco airport, Dr. Steve Simmons cam...

  More News

 

04/30/2002 - MatriCal Joins SIRTI Incubator

A biotechnology business cluster is incubating in the Terabyte Triangle. The latest addition is MatriCal, Inc. a company that specializes in “integrated solutions for the drug discovery market.” MatriCal moved its corporate headquarters into the SIRTI incubator where they now occupy 3000 square feet of research and development space. MatriCal also maintains a production facility at Milton, Delaware.

MatriCal’s Managing Director, Kevin Oldenburg, Ph. D., chose the region for its outdoor quality-of-life, and Spokane specifically because of its high technology corridor. At SIRTI, the company is just across the river from Gonzaga University and a relatively short distance from Eastern Washington University, Washington State University, the University of Idaho, and even the University of Washington. “This provides our scientists with access to a great academic environment and academic collaborations,” says Oldenburg. “In addition, there is access to a highly skilled and trained pool of scientists and engineers.” At SIRTI, MatriCal has state-of-the-art laboratories and engineering facilities, as well as conference and training facilities, multimedia services, and high-speed Internet connections.

Dr. Oldenburg’s background is in biopharmaceuticals – that is, pharmaceutical treatments that are engineered to mimic the body’s naturally occurring chemistry. During “discovery”, there is first the identification of a protein or other biological target linked to a particular disease. This phase is followed by subsequent identification of a potential drug that interacts with the target to help cure the disease. The identification phase may include testing of up to 1,000,000 samples.

The process of drug discovery has become an extraordinarily high volume business. Pressure is on the drug discovery laboratory to move faster, do more assays, and get more results --- while keeping all the costs down. To do this, biopharmaceutical companies need more tools --- more solutions. The creation of specialized tools to solve biopharmaceutical problems is MatriCal’s business.

MatriCal has three products in production, and two new ones to be released this year. Their first product was the “MatriPlate™,” which is an assay plate used in the ‘discovery’ identification phase. Also in production are the “MatriStore™,” and “MatriPickTM” which are a large-scale chemical compound storage and retrieval systems. The new products include the “MatriCycler™,” which is a high throughput thermal cycling system for the genomics market. Genomics is the study of genetic material in the chromosomes of a particular organism.

For more information, go to http://www.matrical.com/index.htm


Billie Moreland
 
» News Archive
Search:  

Sirti Bestows Award of Honor
Triangle %u201CGraduates%u201D at Sweet Sixteen
Triangle Concludes Newsletter Operations
ISAGA 2010 Conference Slated at Riverpoint
Terabyte Tidbits
Education Robotics Expands in Region
Terabyte Tidbits
Triangle Welcomes Caelus Consulting
Area High Schools Join Robotics Competition
Terabyte Tidbits
Triangle Welcomes Apple Guy
Fine Solutions Offers Flexible ERP
Lewis and Clark Robotics Faces FIRST Showdown
Terabyte Tidbits
Interlink Debuts Surveillance System
Spokane Entrepreneurial Center
Terabyte Tidbits
EWU Computer Science Celebrates 25 Years
Terabyte Tidbits
Triangle Welcomes Spokane Web Communications

1